España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Merus
MRUS
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$41.85
-0.24
-0.57%
At close: -
$41.85
0.00
0.00%
After Hours: Dec 20, 4:00 PM EDT
Get Report
Comment
Merus (MRUS) Forecast
News
Earnings
Merus (MRUS) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Merus (NASDAQ:MRUS) Stock
Merus Stock (NASDAQ: MRUS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, December 16, 2024
Merus announces First Patient Dosed In The Ph...
Benzinga Newsdesk
Tuesday, December 10, 2024
Citigroup Maintains Buy on Merus, Raises Pric...
Benzinga Newsdesk
Monday, December 09, 2024
Needham Reiterates Buy on Merus, Maintains $8...
Benzinga Newsdesk
Reported Saturday, Merus Unveils Clinically M...
Benzinga Newsdesk
Thursday, December 05, 2024
Merus Scores Its First FDA Approval For Lung Cancer Drug
Vandana Singh
Guggenheim Maintains Buy on Merus, Raises Pri...
Benzinga Newsdesk
Jim Cramer: This Health Care Stock Is 'Very, Very Speculative'
Avi Kapoor
HC Wainwright & Co. Reiterates Buy on Merus, ...
Benzinga Newsdesk
Needham Reiterates Buy on Merus, Maintains $8...
Benzinga Newsdesk
Wednesday, December 04, 2024
Merus Announces FDA Approval Of BIZENGRI For ...
Benzinga Newsdesk
FDA Grants Accelerated Approval To Zenocutuzu...
Benzinga Newsdesk
Tuesday, December 03, 2024
Guggenheim Reiterates Buy on Merus, Lowers Pr...
Benzinga Newsdesk
Monday, December 02, 2024
Merus Licenses US Commercialization Rights For Cancer Potential Zenocutuzumab, Analyst Highlight Merus' Pipeline
Vandana Singh
XPeng, NovoCure, Merus, Gap And Other Big Stocks Moving Higher On Monday
Avi Kapoor
Merus shares are trading higher after the com...
Benzinga Newsdesk
Merus And Partner Therapeutics Have Entered I...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Merus, ...
Benzinga Newsdesk
Needham Reiterates Buy on Merus, Maintains $8...
Benzinga Newsdesk
Sunday, December 01, 2024
Merus Earlier Announced Publication On Abstra...
Benzinga Newsdesk
Thursday, November 21, 2024
This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Avi Kapoor
Merus shares are trading higher after Goldman...
Benzinga Newsdesk
Goldman Sachs Initiates Coverage On Merus wit...
Benzinga Newsdesk
Wednesday, November 20, 2024
Needham Reiterates Buy on Merus, Maintains $8...
Benzinga Newsdesk
Tuesday, November 05, 2024
Merus Says FDA Extended PDUFA Goal Date For Z...
Benzinga Newsdesk
Friday, November 01, 2024
HC Wainwright & Co. Reiterates Buy on Merus, ...
Benzinga Newsdesk
Needham Reiterates Buy on Merus, Maintains $8...
Benzinga Newsdesk
Thursday, October 31, 2024
Merus Q3 EPS $(1.46) Misses $(0.89) Estimate,...
Benzinga Newsdesk
Thursday, October 24, 2024
UBS Initiates Coverage On Merus with Buy Rati...
Benzinga Newsdesk
Tuesday, October 01, 2024
Guggenheim Maintains Buy on Merus, Raises Pri...
Benzinga Newsdesk
Monday, September 30, 2024
Merus Announces First Patient Dosed In LiGeR-...
Benzinga Newsdesk
Wednesday, August 28, 2024
Foundation Medicine and Merus Collaborate on ...
Benzinga Newsdesk
Monday, August 05, 2024
Needham Maintains Buy on Merus, Lowers Price ...
Benzinga Newsdesk
Thursday, August 01, 2024
Merus Q2 EPS $(0.81) Misses $(0.76) Estimate,...
Benzinga Newsdesk
Thursday, July 25, 2024
Canaccord Genuity Maintains Buy on Merus, Mai...
Benzinga Newsdesk
Wednesday, July 24, 2024
Merus Announced That The First Patient Has Be...
Benzinga Newsdesk
Monday, July 08, 2024
Merus N.V. Doses First Patient In Phase 2 Tri...
Benzinga Newsdesk
Friday, June 28, 2024
Needham Reiterates Buy on Merus, Maintains $9...
Benzinga Newsdesk
Wednesday, June 26, 2024
Citigroup Maintains Buy on Merus, Raises Pric...
Benzinga Newsdesk
Tuesday, June 25, 2024
B of A Securities Maintains Buy on Merus, Mai...
Benzinga Newsdesk
Monday, June 17, 2024
Stifel Maintains Buy on Merus, Raises Price T...
Benzinga Newsdesk
Wednesday, June 05, 2024
B of A Securities Maintains Buy on Merus, Low...
Benzinga Newsdesk
Tuesday, June 04, 2024
BMO Capital Maintains Outperform on Merus, Ra...
Benzinga Newsdesk
Truist Securities Maintains Buy on Merus, Rai...
Benzinga Newsdesk
Monday, June 03, 2024
Merus' MCLA-129 Demonstrates Single-Agent Eff...
Benzinga Newsdesk
Sunday, June 02, 2024
Merus Presented Interim Data On MCLA-145 Monotherapy And In Combination With Pembrolizumab At ASCO 2024
Charles Gross
Thursday, May 30, 2024
Reported Earlier, Merus Prices Upsized Public...
Benzinga Newsdesk
Wednesday, May 29, 2024
B of A Securities Maintains Buy on Merus, Rai...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on Merus, R...
Benzinga Newsdesk
Tuesday, May 28, 2024
Merus Announces $300M Proposed Public Offerin...
Benzinga Newsdesk
Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Show More